Results 161 to 170 of about 37,136 (206)
Some of the next articles are maybe not open access.

Scleroderma-Inducing Glycosaminoglycan in the Urine of Patients with Systemic Scleroderma

Dermatologica, 2009
A glycosaminoglycan with scleroderma-inducing effect was isolated and partially purified from the urine of patients with systemic scleroderma. The glycosaminoglycan was an N-sulfated glycosaminoglycuronan and its high total sulfate and 2,5-anhydromannose contents suggest that the glycosaminoglycan is a degradation product of heparin or polysulfated ...
H, Ishikawa   +3 more
openaire   +2 more sources

IMMUNOGLOBULINS IN SYSTEMIC SCLERODERMA

Mayo Clinic Proceedings, 1971
S K, Spencer, R K, Winkelmann
openaire   +2 more sources

Systemic Sclerosis (Scleroderma)

2020
Shervin Assassi, John Varga
openaire   +1 more source

[Systemic scleroderma].

La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1984
The etiology of systemic scleroderma is still unknown. This disease is well individualized by its usual forms, i.e. acrosclerosis and diffuse form, whose features and prognosis differ. The description of new entities has generated further interest, particularly through a different diagnostic and therapeutic approach. No specific biologic or immunologic
openaire   +1 more source

Systemic propagation of immunity in plants

New Phytologist, 2021
A Corina Vlot   +2 more
exaly  

Systemic Sclerosis: Scleroderma

International Journal of Dermatology, 1990
openaire   +2 more sources

Systemic sclerosis

Nature Reviews Disease Primers, 2015
Yannick Allanore   +2 more
exaly   +2 more sources

Systemic treatment of cancer

Ca-A Cancer Journal for Clinicians, 1996
Irwin H Krakoff
exaly  

Autoimmunity and organ damage in systemic lupus erythematosus

Nature Immunology, 2020
George C Tsokos, Tsokos George C
exaly  

Home - About - Disclaimer - Privacy